Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA).
Life (Basel)
; 12(7)2022 Jun 27.
Article
in En
| MEDLINE
| ID: mdl-35888056
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Life (Basel)
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
Switzerland